FDA approves first postpartum depression pill

The Food and Drug Administration approved the drug, called Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. It's taken once a day for 14 days.

FDA approves first postpartum depression pill in the US - WSVN 7News, Miami News, Weather, Sports

First Pill for Postpartum Depression Is Approved by FDA - WSJ

FDA Approves First Postpartum Depression Pill

FDA Approves First Oral Treatment for Postpartum Depression - Mega Doctor News

FDA Approves First Pill for Postpartum Depression

The New York Times on X: Breaking News: The FDA approved a pill for postpartum depression, a milestone that could increase and improve treatment of a condition afflicting many women. /

FDA Approves New Postpartum Depression Pill

FDA approves first postpartum depression pill

F.D.A. Approves First Drug for Treating Postpartum Depression, Smart News

Zuranolone FDA approval adds treatment option for women with

FDA approves first postpartum depression pill

FDA approves first postpartum depression pill in the US